Therapeutics, Targets, and Chemical Biology
Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model
Fei Huang, Warren Hurlburt, Ann Greer, Karen A. Reeves, Stephen Hillerman, Han Chang, Joseph Fargnoli, Friedrich Graf Finckenstein, Marco M. Gottardis and Joan M. Carboni
Fei Huang
Warren Hurlburt
Ann Greer
Karen A. Reeves
Stephen Hillerman
Han Chang
Joseph Fargnoli
Friedrich Graf Finckenstein
Marco M. Gottardis
DOI: 10.1158/0008-5472.CAN-10-0391 Published September 2010

Article Figures & Data
Additional Files
Supplementary Data, Huang, et al.
Files in this Data Supplement:
September 2010
Volume 70, Issue 18
Volume 70, Issue 18
Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model
Fei Huang, Warren Hurlburt, Ann Greer, Karen A. Reeves, Stephen Hillerman, Han Chang, Joseph Fargnoli, Friedrich Graf Finckenstein, Marco M. Gottardis and Joan M. Carboni
Cancer Res September 15 2010 (70) (18) 7221-7231; DOI: 10.1158/0008-5472.CAN-10-0391
Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model
Fei Huang, Warren Hurlburt, Ann Greer, Karen A. Reeves, Stephen Hillerman, Han Chang, Joseph Fargnoli, Friedrich Graf Finckenstein, Marco M. Gottardis and Joan M. Carboni
Cancer Res September 15 2010 (70) (18) 7221-7231; DOI: 10.1158/0008-5472.CAN-10-0391
Jump to section
Advertisement